Warner Chilcott Limited announced that its subsidiary Warner Chilcott Company, Inc and Barr Laboratories, Inc, a subsidiary of Barr Pharmaceuticals, Inc, have entered into a settlement and license agreement to resolve the pending patent litigation involving Warner Chilcott's oral contraceptive product, Femcon Fe.
The details can be read here.
No comments:
Post a Comment